| Primary |
| Hypertension |
27.5% |
| Benign Prostatic Hyperplasia |
8.7% |
| Congestive Cardiomyopathy |
8.7% |
| Post-traumatic Stress Disorder |
8.7% |
| Type 2 Diabetes Mellitus |
8.7% |
| Familial Mediterranean Fever |
5.8% |
| Nightmare |
5.8% |
| Depression |
2.9% |
| Diabetes Insipidus |
2.9% |
| Hyperkalaemia |
2.9% |
| Hypertriglyceridaemia |
2.9% |
| Hyperuricaemia |
2.9% |
| Acne |
1.4% |
| Blood Glucose Increased |
1.4% |
| Blood Pressure |
1.4% |
| Colorectal Cancer |
1.4% |
| Convulsion |
1.4% |
| Epilepsy |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Insomnia |
1.4% |
|
| Syncope |
14.7% |
| Hypotension |
11.8% |
| Priapism |
8.8% |
| Bradycardia |
5.9% |
| Fall |
5.9% |
| Headache |
5.9% |
| Photopsia |
5.9% |
| Treatment Noncompliance |
5.9% |
| Aortic Valve Disease |
2.9% |
| Bladder Cancer |
2.9% |
| Bladder Transitional Cell Carcinoma Stage Ii |
2.9% |
| Completed Suicide |
2.9% |
| Dissociative Disorder |
2.9% |
| Drug Ineffective |
2.9% |
| Dyspnoea |
2.9% |
| Fatigue |
2.9% |
| General Physical Health Deterioration |
2.9% |
| Gynaecomastia |
2.9% |
| Hyperhidrosis |
2.9% |
| Medication Error |
2.9% |
|
| Secondary |
| Hypertension |
15.8% |
| Type 2 Diabetes Mellitus |
14.4% |
| Congestive Cardiomyopathy |
12.3% |
| Drug Use For Unknown Indication |
11.6% |
| Diabetes Insipidus |
4.8% |
| Hyperuricaemia |
4.8% |
| Bipolar Disorder |
4.5% |
| Hyperkalaemia |
4.5% |
| Hypertriglyceridaemia |
4.5% |
| Renovascular Hypertension |
3.1% |
| Premedication |
2.7% |
| Pain |
2.4% |
| Blood Pressure Increased |
2.1% |
| Cardiovascular Disorder |
2.1% |
| Nephrotic Syndrome |
2.1% |
| Pre-eclampsia |
2.1% |
| Product Used For Unknown Indication |
2.1% |
| Suicide Attempt |
1.7% |
| Headache |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
|
| Bladder Cancer |
11.1% |
| Completed Suicide |
8.9% |
| Orthostatic Hypotension |
6.7% |
| Sarcoidosis |
6.7% |
| Abnormal Dreams |
4.4% |
| Aortic Valve Disease |
4.4% |
| Asthenia |
4.4% |
| Bladder Transitional Cell Carcinoma Stage Ii |
4.4% |
| Cardiomyopathy |
4.4% |
| Condition Aggravated |
4.4% |
| Dehydration |
4.4% |
| Head Injury |
4.4% |
| Reaction To Drug Excipients |
4.4% |
| Respiratory Arrest |
4.4% |
| Type 2 Diabetes Mellitus |
4.4% |
| Urinary Incontinence |
4.4% |
| Vomiting |
4.4% |
| Weight Decreased |
4.4% |
| Autonomic Nervous System Imbalance |
2.2% |
| Blood Ph Decreased |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
21.4% |
| Hypertension |
16.7% |
| Product Used For Unknown Indication |
11.2% |
| Pain |
8.3% |
| Depression |
6.7% |
| Blood Pressure |
4.5% |
| Diabetes Mellitus |
3.8% |
| Anxiety |
3.6% |
| Prophylaxis |
2.8% |
| Atrial Fibrillation |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Nightmare |
2.1% |
| Post-traumatic Stress Disorder |
2.1% |
| Insomnia |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Sleep Disorder |
1.9% |
| Blood Cholesterol Increased |
1.6% |
| Cardiac Disorder |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.6% |
| Nuclear Magnetic Resonance Imaging |
1.6% |
|
| Renal Failure Acute |
10.7% |
| Weight Decreased |
8.7% |
| Tremor |
7.4% |
| Renal Failure |
6.0% |
| Pulmonary Embolism |
5.4% |
| Nausea |
4.7% |
| Pneumonia |
4.7% |
| Vomiting |
4.7% |
| Weight Increased |
4.7% |
| Cardiac Arrest |
4.0% |
| Cardiac Failure |
4.0% |
| Death |
4.0% |
| Drug Ineffective |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Lung Disorder |
4.0% |
| Pulmonary Fibrosis |
4.0% |
| Septic Shock |
4.0% |
| Sudden Death |
4.0% |
| Cerebrovascular Accident |
3.4% |
| Off Label Use |
3.4% |
|
| Interacting |
| Hypertension |
57.1% |
| Chronic Obstructive Pulmonary Disease |
21.4% |
| Drug Use For Unknown Indication |
14.3% |
| Dyslipidaemia |
7.1% |
|
| Orthostatic Hypotension |
71.4% |
| Malaise |
14.3% |
| Vertigo |
14.3% |
|
